These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2224454)

  • 1. Urinary tissue factor activity in colorectal disease.
    Carty N; Taylor I; Roath OS; el-Baruni K; Francis JL
    Br J Surg; 1990 Oct; 77(10):1091-4. PubMed ID: 2224454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary tissue factor levels in patients with breast and colorectal cancer.
    Lwaleed BA; Chisholm M; Francis JL
    J Pathol; 1999 Feb; 187(3):291-4. PubMed ID: 10398081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor assays as diagnostic tools for cancer? Correlation between urinary and monocyte tissue factor activity.
    Lwaleed BA; Francis JL; Chisholm M
    J Hematother Stem Cell Res; 1999 Dec; 8(6):659-68. PubMed ID: 10645774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary tissue factor activity in malignancy.
    Carty N; Taylor I; Roath OS; el-Baruni K; Francis JL
    Thromb Res; 1990 Feb; 57(3):473-8. PubMed ID: 2315897
    [No Abstract]   [Full Text] [Related]  

  • 5. Urinary tissue factor levels in transitional cell carcinoma of the bladder.
    Adamson AS; Francis JL; Roath OS; Witherow RO; Snell ME
    J Urol; 1992 Aug; 148(2 Pt 1):449-52. PubMed ID: 1378910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary procoagulant activity and tissue factor levels in patients with diabetes mellitus.
    Qi H; Koyama T; Nishida K; Miyasaka N; Hirosawa S
    Haemostasis; 1997; 27(2):57-64. PubMed ID: 9212353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary tissue factor: a potential marker of disease.
    Lwaleed BA; Bass PS; Francis JL
    J Pathol; 1999 May; 188(1):3-8. PubMed ID: 10398132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer.
    Claussen C; Rausch AV; Lezius S; Amirkhosravi A; Davila M; Francis JL; Hisada YM; Mackman N; Bokemeyer C; Schmalfeldt B; Mahner S; Langer F
    Thromb Res; 2016 May; 141():39-48. PubMed ID: 26967531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte tissue factor levels in cancer patients.
    Lwaleed BA; Francis JL; Chisholm M
    Saudi Med J; 2000 Aug; 21(8):722-9. PubMed ID: 11423883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary tissue factor levels in patients with bladder and prostate cancer.
    Lwaleed BA; Francis JL; Chisholm M
    Eur J Surg Oncol; 2000 Feb; 26(1):44-9. PubMed ID: 10718179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of Colon Capsule Endoscopy.
    Pasha SF
    Curr Gastroenterol Rep; 2018 Apr; 20(5):22. PubMed ID: 29644509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A stromal cell population in the large intestine identified by tissue factor expression that is lost during colorectal cancer progression.
    Eriksson O; Asplund A; Hegde G; Edqvist PH; Navani S; Pontén F; Siegbahn A
    Thromb Haemost; 2016 Nov; 116(6):1050-1059. PubMed ID: 27656710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonoscopy in symptomatic patients with positive family history of colorectal cancer.
    Charalambopoulos A; Syrigos KN; Ho JL; Murday VA; Leicester RJ
    Anticancer Res; 2000; 20(3B):1991-4. PubMed ID: 10928139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.
    Mpofu C; Watson AJ; Rhodes JM
    Cochrane Database Syst Rev; 2004; (2):CD000279. PubMed ID: 15106148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and endoscopic features of non-steroidal anti-inflammatory drug-induced colorectal ulcerations.
    Pan YS; Chen LT; Tseng CA; Su YC; Jan CM; Wang WM; Tsai KB
    J Formos Med Assoc; 2005 Nov; 104(11):804-10. PubMed ID: 16496059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urinary level of tissue factor and its procoagulant activity in patients with type 2 diabetes].
    Fu WJ; Zheng L; Wang Q; Deng RT; Ye CQ; Wang SB; Peng LF; Xiong SL; Tang HH
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 May; 31(5):878-81. PubMed ID: 21602148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary tissue factor levels in neoplastic diseases.
    Lwaleed BA; Francis JL; Chisholm M
    Ann Saudi Med; 2000; 20(3-4):197-201. PubMed ID: 17322656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole blood tissue factor procoagulant activity remains detectable during severe aplasia following bone marrow and peripheral blood stem cell transplantation.
    Ozcan M; Morton CT; Solovey A; Dandelet L; Bach RR; Hebbel RP; Slungaard A; Key NS
    Thromb Haemost; 2001 Feb; 85(2):250-5. PubMed ID: 11246542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of tissue factor expression in the invasive and metastatic ability of colorectal carcinoma].
    Wan YL; Yao HW; Ye JM; Liu YC; Wu T; Wang X; Pan YS; Wu N; Ju XM; Zhu J; Huang YT
    Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):149-53. PubMed ID: 15062059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procoagulant activity in whole blood from patients with breast and colorectal cancer.
    Parmar J; Taylor I; Roath S; Francis J
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):127-32. PubMed ID: 2130924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.